A20 JOHN WOOLLEY BUILDING
UNIVERSITY OF SYDNEY
CAMPERDOWN, 2006
Australia
The University of Sydney
Sodium-Glucose Transporter 2 Inhibitors, chronic kidney disease progression, cardiovascular disease, mortality, Heart failure, diabetes mellitus
Sodium-Glucose Transporter 2 Inhibitors, Glucagon-Like Peptide-1 receptor agonist, diabetes mellitus type 2, comparative effectiveness, cardiovascular drug, cohort observational study